Taurine and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Taurine (taurine), especially for people who are female, 60+ old, also take Vitamin C, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Weakness when taking Taurine. It is created by eHealthMe based on reports of 929 people who have side effects when taking Taurine from the FDA, and is updated regularly.

What is Taurine?

Taurine has active ingredients of taurine. eHealthMe is studying from 1,015 Taurine users. Check the latest studies of Taurine.

What is Weakness?

Weakness is found to be associated with 3,642 drugs and 6,611 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 06, 2026

929 people reported to have side effects when taking Taurine.
Among them, 31 people (3.34%) have Weakness.

Among these 31 people:

What is the gender of people who have Weakness when taking Taurine? *

female: 64.52 %
male: 35.48 %

What is the age of people who have Weakness when taking Taurine? *

What are other drugs people take besides Taurine? *

Coumadin: 7 people, 22.58%
Diltiazem Hydrochloride: 7 people, 22.58%
Chondroitin: 7 people, 22.58%
Vitamin C: 7 people, 22.58%
Vitamin E: 6 people, 19.35%
Magnesium: 5 people, 16.13%
Vitamin D3: 5 people, 16.13%
Oxycodone: 4 people, 12.90%
Synthroid: 4 people, 12.90%
Melatonin: 4 people, 12.90%

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 15 people, 48.39%
Pain In Extremity: 14 people, 45.16%
Headache (pain in head): 13 people, 41.94%
Back Pain: 11 people, 35.48%
Oedema Peripheral (superficial swelling): 11 people, 35.48%
Balance Disorder: 10 people, 32.26%
Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 32.26%
Joint Pain: 10 people, 32.26%
Fall: 9 people, 29.03%
Abdominal Distension: 8 people, 25.81%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 29.03%
Muscle Spasms (muscle contraction): 4 people, 12.90%
Osteoporosis (bones weak and more likely to break): 3 people, 9.68%
Asthma: 3 people, 9.68%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 9.68%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 6.45%
Diabetes: 2 people, 6.45%
Herpes Zoster: 2 people, 6.45%
Constipation: 2 people, 6.45%
Laxative Supportive Care: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Taurine and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taurine:

Taurine (1,015 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Taurine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,642 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,611 conditions)

Related publications that referenced our studies

Taziki S, Sattari MR, Egbal MA, "Evaluation of amitriptyline-induced toxicity in freshly isolated rat hepatocytes and the protective role of taurine", Life Sci J, 2015 Jan .
Taziki S, Sattari MR, Egbal MA, "Evaluation of amitriptyline-induced toxicity in freshly isolated rat hepatocytes and the protective role of taurine", Life Sci J, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on taurine (the active ingredients of Taurine) and Taurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.